Count | |
6 | |
6 | |
1 | |
1 | |
1 | |
1 | |
1 | |
4 | |
2 | |
Insulin/adverse effects/*analogs & derivatives/blood/*therapeutic use | 1 |
81 | |
112 | |
1 | |
1 | |
1 | |
2 | |
1 | |
2 | |
2 | |
3 | |
2 | |
1 | |
5 | |
1 | |
16 | |
1 | |
1 | |
1 | |
3 | |
2 | |
7 | |
13 | |
2 | |
1 | |
1 | |
16 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
1 | |
Insulin/administration & dosage/pharmacology/*therapeutic use | 2 |
2 | |
Insulin/administration & dosage/adverse effects/therapeutic use | 1 |
Insulin, Long-Acting/*administration & dosage/therapeutic use | 1 |
Insulin-Like Growth Factor I/*metabolism/pharmacology/therapeutic use | 1 |
Insulin-Like Growth Factor I/adverse effects/*therapeutic use | 1 |
Insulin-Like Growth Factor I/*genetics/metabolism/therapeutic use | 1 |
Insulin, Isophane/chemical synthesis/*metabolism/therapeutic use | 1 |
Insulin-Like Growth Factor I/adverse effects/analysis/*therapeutic use | 1 |
173 | |
665 | |
12 | |
1 | |
3 | |
1 | |
1 | |
1 | |
10 | |
1 | |
4 | |
2 | |
2 | |
9 | |
1 | |
1 | |
1 | |
1 | |
1 | |
6 | |
1 | |
19 | |
1 | |
4 | |
49 | |
2 | |
1 | |
21 | |
2 | |
4 | |
3 | |
2 | |
1 | |
6 | |
2 | |
10 | |
1 | |
1 | |
3 | |
4 | |
17 | |
5 | |
1 | |
1 | |
1 | |